Skip to content

Side-by-side contrast-enhanced ultrasound (CEUS) for the early evaluation of hepatocellular carcinoma after microwave ablation

Side-by-side contrast-enhanced ultrasound (CEUS) for the early evaluation of hepatocellular carcinoma after microwave ablation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017561
Enrollment
Unknown
Registered
2018-08-04
Start date
2018-08-10
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Gold Standard:Enhanced CT and MRI findings or long-term follow-up results 1 month after microwave ablation
Index test:Side-by-side&#32
contrast-enhanced&#32
ultrasound&#32
(CEUS)&#32
by&#32
system&#32
America).

Sponsors

1st Bethune Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathological or clinical diagnosis of hepatocellular carcinoma; 2. The diameter of a single tumor is no more than 5cm, or the number of tumors is no more than 3, and the maximum diameter is no more than 3cm.

Exclusion criteria

Exclusion criteria: 1. Prothrombin time > 30 s, prothrombin activity < 40%, platelet count < 30×10^9/L cells; 2. Severe heart, liver, renal and lung dysfunction; 3. Pregnant or lactating women; 4. Patients had a history of ultrasound contrast agent and CT/MRI contrast agent hypersensitivity; 5. Postoperative pathology confirmed that non-HCC or patients uncoordinated follow-up; 6. With portal vein cancerous thrombus, or extrahepatic metastasis; 7. The lesions had been treated before.

Design outcomes

Primary

MeasureTime frame
Tumor size;The number of tumor;Tumor location;Postoperative necrotic area;Postoperative enhanced CT and MRI findings;Long-term follow-up results;

Countries

China

Contacts

Public ContactDezhi Zhang

1st Bethune Hospital of Jilin University

zhangdezhi1982@163.com+86 18186876068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026